Have a personal or library account? Click to login
Glioblastoma: A molecular insight into current discoveries and treatment directions Cover

Glioblastoma: A molecular insight into current discoveries and treatment directions

Medical Journal of Cell Biology
Volume 12 (2024): Issue 1 (July 2024)
By: Wiktor Świątek,  Olgierd Kłodziński,  Michał Ciesielski,  Zuzann a Adamkiewicz,  Marcin Podolak,  Paul Edward Mozdziak and  Wiesława Kranc  
Open Access
|Jul 2024

Authors

Wiktor Świątek

Department of Anatomy, Poznan University of Medical Sciences, Poznan, Poland

Olgierd Kłodziński

Department of Anatomy, Poznan University of Medical Sciences, Poznan, Poland

Michał Ciesielski

Department of Anatomy, Poznan University of Medical Sciences, Poznan, Poland

Zuzann a Adamkiewicz

Department of Anatomy, Poznan University of Medical Sciences, Poznan, Poland

Marcin Podolak

Department of Anatomy, Poznan University of Medical Sciences, Poznan, Poland

Paul Edward Mozdziak

Graduate Physiology Program, North Carolina State University, Raleigh, USA
Prestage Department of Poultry Sciences, North Carolina State University, USA

Wiesława Kranc

wkranc@ump.edu.pl

Department of Anatomy, Poznan University of Medical Sciences, Poznan, Poland
DOI: https://doi.org/10.2478/acb-2024-0001 | Journal eISSN: 2544-3577
Journal RSS Feed
Language: English
Page range: 1 - 20
Submitted on: Feb 15, 2024
Accepted on: Apr 10, 2024
Published on: Jul 5, 2024
Published by: Foundation for Cell Biology and Molecular Biology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
glioblastoma,
GBM,
IDH,
EGFR,
GSC,
TME
Related subjects:
Life sciences,
Molecular biology,
Biochemistry

© 2024 Wiktor Świątek, Olgierd Kłodziński, Michał Ciesielski, Zuzann a Adamkiewicz, Marcin Podolak, Paul Edward Mozdziak, Wiesława Kranc, published by Foundation for Cell Biology and Molecular Biology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 12 (2024): Issue 1 (July 2024)Next article